Managing Director and Academic Lead, Dr Mikael Sodergren, contributes to Elisabeth Mahase’s feature in this week’s bmj ‘Medical Cannabis: patients turn to private clinics because of NHS void’.
We aim to make things easy and to keep you informed of your progress every step of the way, from the moment you apply to the receipt of your prescription(s).
Managing Director and Academic Lead, Dr Mikael Sodergren, contributes to Elisabeth Mahase’s feature in this week’s bmj ‘Medical Cannabis: patients turn to private clinics because of NHS void’.
Endometriosis is a chronic inflammatory condition affecting an estimated 6% to 10% of reproductive-age women. It is characterised ...
The Netherlands is famous for its long-standing “tolerance policy” (known as gedoogbeleid), which permits the sale of small ...
Endometriosis is a chronic condition that is estimated to affect around 176 million women globally, and approximately 1 ...
Fibromyalgia is a chronic pain condition characterised by generalised pain lasting at least three months. The condition is ...
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by a persistent pattern of inattention, hyperactivity-impulsivity, or both. It ...
Throughout history, the cannabis plant has been used for a wide range of therapeutic purposes, including for pain ...
Autism spectrum disorder (ASD) is a developmental brain condition that is now the ninth leading cause of neurological ...
Since November 2018, cannabis-based medicinal products (CBMPs) have been legally available in the UK through specialist doctors. A ...
The use of medical cannabis which includes compounds like delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), is increasing, particularly among ...